Future direction structured knowledge objects and ontologies for tech transfer

Future Direction Structured Knowledge Objects and Ontologies for Tech Transfer Future Direction Structured Knowledge Objects and Ontologies for Tech Transfer In the dynamic landscape of pharmaceutical development and manufacturing, ensuring quality and compliance is paramount. One critical area that demands attention is the transfer of knowledge between different stages of production and across facilities, which is addressed through technology transfer principles and corresponding guidelines. This article explores the future of structured knowledge objects and ontologies in the context of tech transfer, delves into current guidelines, and outlines the implications for process validation and product quality. Understanding Technology Transfer in Pharmaceuticals…

Continue Reading... Future direction structured knowledge objects and ontologies for tech transfer

Metrics to monitor effectiveness of process knowledge transfer during scale up

Metrics to Monitor Effectiveness of Process Knowledge Transfer During Scale Up The process of transferring knowledge during scale-up activities in pharmaceutical manufacturing is a critical element of ensuring the continued quality, efficacy, and safety of drug products. Effective process knowledge transfer aids in mitigating risks associated with changes in manufacturing conditions and ensures compliance with regulatory expectations set forth by agencies such as the US FDA. This article explores various metrics to monitor the effectiveness of process knowledge transfer, especially in relation to process validation guidelines, control strategy mapping, and the principles behind process validation. Understanding Process Knowledge Transfer Process…

Continue Reading... Metrics to monitor effectiveness of process knowledge transfer during scale up

Training receiving site teams on critical CQAs CPPs and control strategy elements

Training Receiving Site Teams on Critical CQAs CPPs and Control Strategy Elements Training Receiving Site Teams on Critical CQAs CPPs and Control Strategy Elements In the landscape of pharmaceutical manufacturing and quality assurance, ensuring a seamless transition of process knowledge during technology transfer is paramount. This involves a detailed understanding of critical quality attributes (CQAs) and critical process parameters (CPPs), alongside the control strategies that govern them. Following FDA process validation guidance and other international regulations is vital for success. This article aims to delineate the necessary training steps for receiving site teams while emphasizing the role these elements play…

Continue Reading... Training receiving site teams on critical CQAs CPPs and control strategy elements

Global regulatory expectations for documented process understanding in Module 3

Global Regulatory Expectations for Documented Process Understanding in Module 3 Global Regulatory Expectations for Documented Process Understanding in Module 3 The increasing complexity of pharmaceutical manufacturing necessitates a rigorous approach to process validation and understanding. Module 3 of the Common Technical Document (CTD) provides the framework for demonstrating quality through sufficient documentation of processes involved in drug development and manufacturing. This guide will elaborate on the global regulatory expectations surrounding documented process understanding, especially with the focus on the FDA process validation guidance and how it aligns with other international standards. Overview of Process Validation Expectations Process validation is a…

Continue Reading... Global regulatory expectations for documented process understanding in Module 3